Connect Education Workshop Details
Help
Updates on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Part II: Complications, Clinical Trials and New Approaches
- Complications, Clinical Trials and New Approaches
Richard R. Furman, MD Director, CLL Research Center, Weill Cornell Medical College, New York Presbyterian Hospital |
|
Clive S. Zent, MD Consultant Hematologist, Associate Professor of Medicine, Mayo Clinic |
|
Jennifer Mills, LMSW, MPH National Director, Patient Programs, Lymphoma Research Foundation |
|
John Balan Founder, CLL Information Group |
|
Richard Dickens, MSW Blood Cancers Program Coordinator, Project Coordinator, Mind/Body Program, CancerCare |
|
American Cancer Society, American Pain Foundation, American Society of Clinical Oncology, Association of Clinicians for the Underserved, Association of Oncology Social Work, Black Women's Health Imperative, Cancer Patient Education Network, CLL Information Group, Education Network to Advance Cancer Clinical Trials, Intercultural Cancer Council, Lymphoma Research Foundation, Multinational Association of Supportive Care in Cancer, National Center for Frontier Communities, National Coalition for Cancer Survivorship, Pathways to Prevention, Research Advocacy Network, The Wellness Community
This program is supported by an unrestricted educational grant to the Lymphoma Research Foundation from Cephalon Oncology.
July 24, 2008
- Connect® Education Workshop Podcasts
- Updates on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Part I: Overview and Treatment Options
- Marrow or Cord Blood Transplant as a Treatment Option
- Connect® Booklets
